Oral microbiota of patients with phenylketonuria: A nation-based cross-sectional study
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Germany
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Phenylketonuria Folling disease,Folling's disease,Folling's syndrome,Følling's disease,HPA, non-PKU mild,hyperphenylalaninemia, non-PKU mild,imbecilitus phenylpyruvica,oligophrenia Phenylpyruvica,oligophrenia phenylpyruvica,PAH deficiency,Pah deficiency,pah deficiency,Phenylalanine hydroxylase deficiency,phenylalanine hydroxylase deficiency,phenylalaninemia,phenylketonuria,phenylketonuria, maternal,phenylpyruvic oligophrenia,PKU,Phenylketonuria
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Saliva (Ctrl-S) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Saliva (PKU-S) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients diagnosed with Phenylketonuria (PKU) and who stimulated Saliva samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 114
- Group 1 sample size Number of subjects in the case (exposed) group
- 109
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V1-V2
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- Matched on Factors on which subjects have been matched on in a case-control study
- age
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- increased
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Richness Number of species
- decreased
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- decreased
Signature 1
Source: Appendix Table 5, Figure 2D
Description: Differential abundant genera in Phenylketonuria (PKU-S) and Control (Ctrl-S) Saliva Patients.
Abundance in Group 1: increased abundance in Phenylketonuria Saliva (PKU-S) patients
NCBI | Quality Control | Links |
---|---|---|
Campylobacter | ||
Haemophilus | ||
Veillonella |
Signature 2
Source: Appendix Table 5, Figure 2D
Description: Differential abundant genera in Phenylketonuria (PKU-S) and Control (Ctrl-S) Saliva Patients.
Abundance in Group 1: decreased abundance in Phenylketonuria Saliva (PKU-S) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomyces | ||
Alloprevotella | ||
Arachnia | ||
Cardiobacterium | ||
Catonella | ||
Olsenella | ||
Peptococcus | ||
Peptostreptococcus | ||
Stomatobaculum | ||
FO332FO332 |
Experiment 2
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Subgingival dental plaque Subgingival plaque,Subgingival dental plaque,subgingival dental plaque
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Subgingival plaque (Ctrl-SP) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Subgingival plaque (PKU-SP) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients diagnosed with Phenylketonuria (PKU) and who stimulated Sub gingival plaque samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 113
- Group 1 sample size Number of subjects in the case (exposed) group
- 96
Lab analysis
Statistical Analysis
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- decreased
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Richness Number of species
- decreased
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Appendix Table 5, Figure 2D
Description: Differential abundant genera in Phenylketonuria (PKU-SP) and Control (Ctrl-SP) Subgingival Patients.
Abundance in Group 1: increased abundance in Phenylketonuria Subgingival plaque (PKU-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomyces |
Signature 2
Source: Appendix Table 5, Figure 2D
Description: Differential abundant genera in Phenylketonuria (PKU-SP) and Control (Ctrl-SP) Subgingival Patients.
Abundance in Group 1: decreased abundance in Phenylketonuria Subgingival plaque (PKU-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Aggregatibacter | ||
Capnocytophaga | ||
Gemella | ||
Leptotrichia |
Experiment 3
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Adults Saliva (Ctrl-Adults-S) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Adults Saliva (PKU-Adults-S) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Adult Patients diagnosed with Phenylketonuria (PKU) and who stimulated Saliva samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 52
- Group 1 sample size Number of subjects in the case (exposed) group
- 50
Lab analysis
Statistical Analysis
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- unchanged
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Richness Number of species
- decreased
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- decreased
Signature 2
Source: Appendix Table 5, Figure 2D
Description: Differential abundant genera in Phenylketonuria (PKU-Adults-S) and Control (Ctrl-Adults-S) Adult Saliva patients.
Abundance in Group 1: decreased abundance in Phenylketonuria Adults Saliva (PKU-Adults-S) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomyces | ||
Catonella | ||
Peptococcus | ||
Stomatobaculum |
Experiment 4
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Subgingival dental plaque Subgingival plaque,Subgingival dental plaque,subgingival dental plaque
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Adults subgingival plaque (Ctrl-Adults-SP) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Adults subgingival plaque (PKU-Adults-SP) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Adult Patients diagnosed with Phenylketonuria (PKU) and who stimulated Sub gingival plaque samples were gotten from.
- Group 1 sample size Number of subjects in the case (exposed) group
- 45
Lab analysis
Statistical Analysis
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- unchanged
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- decreased
Signature 1
Source: Appendix Table 5, Figure 2D
Description: Differential abundant genera in Phenylketonuria (PKU-Adults-SP) and Control (Ctrl-Adults-SP) Adults Subgingival plaque Patients.
Abundance in Group 1: increased abundance in Phenylketonuria Adults subgingival plaque (PKU-Adults-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomyces |
Experiment 5
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Children Saliva (Ctrl-Ch-S) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Children Saliva (PKU-Ch-S) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Children Patients diagnosed with Phenylketonuria (PKU) and who stimulated Saliva samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 62
- Group 1 sample size Number of subjects in the case (exposed) group
- 59
Lab analysis
Statistical Analysis
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- unchanged
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Appendix Table 5 , Figure 2D
Description: Differential abundant genera in Phenylketonuria Children Saliva (PKU-Ch-S) and Control Children Saliva (Ctrl-Ch-S) Patients
Abundance in Group 1: increased abundance in Phenylketonuria Children Saliva (PKU-Ch-S) patients
NCBI | Quality Control | Links |
---|---|---|
Haemophilus |
Signature 2
Source: Appendix Table 5, Figure 2D
Description: Differential abundant genera in Phenylketonuria Children Saliva (PKU-Ch-S) and Control Children Saliva (Ctrl-Ch-S) Patients
Abundance in Group 1: decreased abundance in Phenylketonuria Children Saliva (PKU-Ch-S) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomyces | ||
Arachnia | ||
Olsenella | ||
Peptococcus | ||
Peptostreptococcus | ||
Selenomonas | ||
FO332FO332 |
Experiment 6
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Subgingival dental plaque Subgingival plaque,Subgingival dental plaque,subgingival dental plaque
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Children subgingival plaque (Ctrl-Ch-SP) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Children subgingival plaque (PKU-Ch-SP) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Children Patients diagnosed with Phenylketonuria (PKU) and who stimulated Sub gingival plaque samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 61
- Group 1 sample size Number of subjects in the case (exposed) group
- 51
Lab analysis
Statistical Analysis
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- unchanged
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Appendix Table 5 , Figure 2D
Description: Differential abundant genera in Phenylketonuria (PKU-Ch-SP) and Control (Ctrl-Ch-SP) Children Subgingival plague Patients.
Abundance in Group 1: increased abundance in Phenylketonuria Children subgingival plaque (PKU-Ch-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomyces |
Signature 2
Source: Appendix Table 5 , Figure 2D
Description: Differential abundant genera in Phenylketonuria (PKU-Ch-SP) and Control (Ctrl-Ch-SP) Children Subgingival plague Patients.
Abundance in Group 1: decreased abundance in Phenylketonuria Children subgingival plaque (PKU-Ch-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Aggregatibacter | ||
Capnocytophaga | ||
Gemella | ||
Leptotrichia |
Experiment 7
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- ChCtrlRel-S [related control children saliva (Healthy siblings of PKU patients)]
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- ChCtrlUnrel-S (unrelated control children saliva) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Control Children unrelated to Phenylketonuria (PKU) patients who stimulated saliva samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 12
- Group 1 sample size Number of subjects in the case (exposed) group
- 26
Lab analysis
Statistical Analysis
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- decreased
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Richness Number of species
- increased
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- increased
Signature 2
Source: Appendix Table 5, Figure 2D
Description: Differential abundant genera in ChCtrlRel-S (related control children saliva) and ChCtrlUnrel-S (unrelated control children saliva) to Phenylketonuria Patients.
Abundance in Group 1: decreased abundance in ChCtrlUnrel-S (unrelated control children saliva) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomyces |
Experiment 8
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- ChPKU-S (PKU children saliva) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Children diagnosed with Phenylketonuria (PKU) and who stimulated Saliva samples were gotten from.
- Group 1 sample size Number of subjects in the case (exposed) group
- 59
Lab analysis
Statistical Analysis
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- unchanged
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Experiment 9
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Oral cavity Bucca,Buccal cavity,Cavity of mouth,Oral cavity,oral cavity
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Saliva (Ctrl-S) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Control Subgingival plaque (Ctrl-SP) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Healthy Controls who stimulated Subgingival plaque samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 114
- Group 1 sample size Number of subjects in the case (exposed) group
- 113
Lab analysis
Statistical Analysis
Signature 1
Source: Appendix Table 10 , Figure 2D
Description: Differential abundant genera in Control Saliva (Ctrl-S) and Control Subgingival Plague (Ctrl-SP) patients
Abundance in Group 1: increased abundance in Control Subgingival plaque (Ctrl-SP) patients
Signature 2
Source: Appendix Table 10 , Figure 2D
Description: Differential abundant genera in Control Saliva (Ctrl-S) and Control Subgingival plague (Ctrl-SP) patients
Abundance in Group 1: decreased abundance in Control Subgingival plaque (Ctrl-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Aggregatibacter | ||
Arachnia | ||
Campylobacter | ||
Capnocytophaga | ||
Cardiobacterium | ||
Corynebacterium | ||
Fusobacterium | ||
Kingella | ||
Leptotrichia | ||
Olsenella | ||
Selenomonas | ||
Tannerella | ||
FO332FO332 |
Experiment 10
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Adults Saliva (Ctrl-Adults-S) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Control Adults Subgingival plaque (Ctrl-Adults-SP) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Healthy Control adults who stimulated Sub gingival plaque samples were gotten from
- Group 0 sample size Number of subjects in the control (unexposed) group
- 52
- Group 1 sample size Number of subjects in the case (exposed) group
- 52
Lab analysis
Statistical Analysis
Signature 1
Source: Appendix Table 10 , Figure 2D
Description: Differential abundant genera in Control Adults Saliva (Ctrl-Adults-S) and Control Adults Subgingival plague (Ctrl-Adults-SP) patients
Abundance in Group 1: increased abundance in Control Adults Subgingival plaque (Ctrl-Adults-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Alloprevotella | ||
Atopobium | ||
Gemella | ||
Haemophilus | ||
Neisseria | ||
Oribacterium | ||
Peptostreptococcus | ||
Porphyromonas | ||
Prevotella | ||
Rothia | ||
Stomatobaculum | ||
Streptococcus | ||
Veillonella |
Signature 2
Source: Appendix Table 10 , Figure 2D
Description: Differential abundant genera in Control Adults Saliva (Ctrl-Adults-S) and Control Adults Subgingival plague (Ctrl-Adults-SP) patients.
Abundance in Group 1: decreased abundance in Control Adults Subgingival plaque (Ctrl-Adults-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Aggregatibacter | ||
Arachnia | ||
Campylobacter | ||
Capnocytophaga | ||
Cardiobacterium | ||
Corynebacterium | ||
Fusobacterium | ||
Selenomonas | ||
Tannerella | ||
F0332F0332 |
Experiment 11
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Children Saliva (Ctrl-Ch-S) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Control Children Subgingival plaque (Ctrl-Ch-SP) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Healthy Control Children without PKU who stimulated Sub gingival plaque samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 62
- Group 1 sample size Number of subjects in the case (exposed) group
- 61
Lab analysis
Statistical Analysis
Signature 1
Source: Appendix Table 10, Figure 2D
Description: Differential abundant genera in Control Children Saliva (Ctrl-Ch-S) and Control children Subgingival plague (Ctrl-Ch-SP) patients.
Abundance in Group 1: increased abundance in Control Children Subgingival plaque (Ctrl-Ch-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Alloprevotella | ||
Atopobium | ||
Gemella | ||
Haemophilus | ||
Neisseria | ||
Oribacterium | ||
Peptostreptococcus | ||
Porphyromonas | ||
Prevotella | ||
Rothia | ||
Stomatobaculum | ||
Streptococcus | ||
Veillonella |
Signature 2
Source: Appendix Table 10 , Figure 2D
Description: Differential abundant genera in Control Children Saliva (Ctrl-Ch-S) and Control children Subgingival plague (Ctrl-Ch-SP) patients.
Abundance in Group 1: decreased abundance in Control Children Subgingival plaque (Ctrl-Ch-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Aggregatibacter | ||
Arachnia | ||
Campylobacter | ||
Capnocytophaga | ||
Cardiobacterium | ||
Corynebacterium | ||
Fusobacterium | ||
Selenomonas | ||
Tannerella | ||
FO332FO332 |
Experiment 12
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Phenylketonuria Saliva (PKU-S) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Subgingival plaque (PKU-SP) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients diagnosed with Phenylketonuria (PKU) and who stimulated Sub gingival plaque samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 109
- Group 1 sample size Number of subjects in the case (exposed) group
- 96
Lab analysis
Statistical Analysis
- Matched on Factors on which subjects have been matched on in a case-control study
- Not specified
Signature 1
Source: Appendix Table 10 , Figure 2D
Description: Differential abundant genera in PKU Saliva (PKU-S) and PKU Subgingival plague (PKU-SP) Patient s
Abundance in Group 1: increased abundance in Phenylketonuria Subgingival plaque (PKU-SP) patients
Signature 2
Source: Appendix Table 10 , Figure 2D
Description: Differneti abundant genera in PKU Saliva (PKU-S) and PKU Subgingival plague (PKU-SP) Patients.
Abundance in Group 1: decreased abundance in Phenylketonuria Subgingival plaque (PKU-SP) patients
Experiment 13
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Phenylketonuria Adults Saliva (PKU-Adults-S)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Adults Subgingival plaque (PKU-Adults-SP)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Adult Patients diagnosed with Phenylketonuria (PKU) and who stimulated Subgingival plaque samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 50
- Group 1 sample size Number of subjects in the case (exposed) group
- 45
Lab analysis
Statistical Analysis
Signature 1
Source: Appendix Table 10 , Figure 2D
Description: Differential abundant genera in PKU Adults Saliva (PKU-Adults-S) and PKU Subgingival plague (PKU-Adults-SP) patients.
Abundance in Group 1: increased abundance in Phenylketonuria Adults Subgingival plaque (PKU-Adults-SP)
NCBI | Quality Control | Links |
---|---|---|
Alloprevotella | ||
Atopobium | ||
Gemella | ||
Haemophilus | ||
Lachnoanaerobaculum | ||
Oribacterium | ||
Peptostreptococcus | ||
Prevotella | ||
Rothia | ||
Stomatobaculum | ||
Streptococcus | ||
Veillonella |
Signature 2
Source: Appendix Table 10, Figure 2D
Description: Differential abundant genera in PKU Adults Saliva (PKU-Adults-S) and PKU Subgingival plague (PKU-Adults-SP) patients.
Abundance in Group 1: decreased abundance in Phenylketonuria Adults Subgingival plaque (PKU-Adults-SP)
NCBI | Quality Control | Links |
---|---|---|
Actinomyces | ||
Arachnia | ||
Campylobacter | ||
Capnocytophaga | ||
Cardiobacterium | ||
Corynebacterium | ||
Fusobacterium | ||
Olsenella | ||
Selenomonas | ||
Tannerella | ||
FO332FO332 |
Experiment 14
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Phenylketonuria Children Saliva (PKU-Ch-S) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Children subgingival plaque (PKU-Ch-SP) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Children diagnosed with Phenylketonuria (PKU) and who stimulated Subgingival plaque samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 59
- Group 1 sample size Number of subjects in the case (exposed) group
- 51
Lab analysis
Statistical Analysis
Signature 1
Source: Appendix Table 10 , Figure 2D
Description: Differential abundant genera in PKU children Saliva (PKU-Ch-S) and PKU Children Subgingival plague (PKU-Ch-SP) patients
Abundance in Group 1: increased abundance in Phenylketonuria Children subgingival plaque (PKU-Ch-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Alloprevotella | ||
Atopobium | ||
Gemella | ||
Haemophilus | ||
Lachnoanaerobaculum | ||
Neisseria | ||
Oribacterium | ||
Porphyromonas | ||
Prevotella | ||
Rothia | ||
Streptococcus | ||
Veillonella |
Signature 2
Source: Appendix Table 10 , Figure 2D
Description: Differential abundant genera in PKU children Saliva (PKU-Ch-S) and PKU Children Subgingival plague (PKU-Ch-SP) patients
Abundance in Group 1: decreased abundance in Phenylketonuria Children subgingival plaque (PKU-Ch-SP) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomyces | ||
Arachnia | ||
Campylobacter | ||
Capnocytophaga | ||
Cardiobacterium | ||
Corynebacterium | ||
Fretibacterium | ||
Fusobacterium | ||
Kingella | ||
Olsenella | ||
Selenomonas | ||
Tannerella | ||
FO332FO332 |
Experiment 15
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control No period (CTRL-S)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria No Period (PKU-S)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients diagnosed with Phenylketonuria (PKU) without suspected Periodontitis and who stimulated Saliva samples were gotten from.
- Group 0 sample size Number of subjects in the control (unexposed) group
- Not specified
- Group 1 sample size Number of subjects in the case (exposed) group
- Not specified
Lab analysis
Statistical Analysis
- Matched on Factors on which subjects have been matched on in a case-control study
- age
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- decreased
Experiment 16
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Period (CTRL-S)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Phenylketonuria Period (PKU-S)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients diagnosed with Phenylketonuria (PKU) with suspected Periodontitis and who stimulated Saliva samples were gotten from.
Lab analysis
Statistical Analysis
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Experiment 17
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Phenylketonuria No Period (PKU-S)
Lab analysis
Statistical Analysis
Alpha Diversity
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- increased
Experiment 18
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CtrlRel-S (control related saliva)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- PKU-Rel-S (Phenylketonuria related saliva) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Controls related to Phenylketonuria (PKU) patients who stimulated saliva samples were gotten from.
Lab analysis
Statistical Analysis
Signature 1
Source: Appendix Table 4
Description: Differential abundant phylum between Ctrl-Rel-S (Control related saliva) patients and PKU-Rel-S (Phenylketonuria related saliva) patients
Abundance in Group 1: increased abundance in PKU-Rel-S (Phenylketonuria related saliva) patients
NCBI | Quality Control | Links |
---|---|---|
Campylobacterota | ||
Patescibacteria group | ||
Spirochaetota |
Signature 2
Source: Appendix Table 4
Description: Differential abundant phylum between Ctrl-Rel-S (Control related saliva) patients and PKU-Rel-S (Phenylketonuria related saliva) patients.
Abundance in Group 1: decreased abundance in PKU-Rel-S (Phenylketonuria related saliva) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomycetota | ||
Other_phylaOther_phyla |
Experiment 19
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CtrlRel-SP (control related subgingival plaque) patients
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- PKU-Rel-SP (Phenylketonuria related subgingival plaque) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Controls related to Phenylketonuria (PKU) patients who stimulated subgingival plaque samples were gotten from.
Lab analysis
Statistical Analysis
Signature 1
Source: Appendix Table 4
Description: Differential abundant phylum between Ctrl-Rel-SP (Control related subgingival plaque) patients and PKU-Rel-SP (Phenylketonuria related subgingival plaque) patients.
Abundance in Group 1: increased abundance in PKU-Rel-SP (Phenylketonuria related subgingival plaque) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomycetota |
Signature 2
Source: Appendix Table 4
Description: Differential abundant phylum between Ctrl-Rel-SP (Control related subgingival plaque) patients and PKU-Rel-SP (Phenylketonuria related subgingival plaque) patients.
Abundance in Group 1: decreased abundance in PKU-Rel-SP (Phenylketonuria related subgingival plaque) patients
NCBI | Quality Control | Links |
---|---|---|
Bacteroidota | ||
Fusobacteriota |
Contents
- 1 Experiment 1
- 2 Experiment 2
- 3 Experiment 3
- 4 Experiment 4
- 5 Experiment 5
- 6 Experiment 6
- 7 Experiment 7
- 8 Experiment 8
- 9 Experiment 9
- 10 Experiment 10
- 11 Experiment 11
- 12 Experiment 12
- 13 Experiment 13
- 14 Experiment 14
- 15 Experiment 15
- 16 Experiment 16
- 17 Experiment 17
- 18 Experiment 18
- 19 Experiment 19